Siemens Healthcare, Malvern, Pa, and Laboratory Corporation of America Holdings, Burlington, NC, have entered a non-exclusive agreement to discuss possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology, and diabetes.
Read More
Companies look to fill the holes in liver diagnostics.
Read MoreNew health care codes went into effect Jan 1 for substance abuse screening and brief intervention.
Read More
Personalized medicine relies on labs to provide diagnostic information that determines the treatment.
Read MoreIn a large-scale, multiethnic study, UCLA researchers have confirmed the role played by three particular molecules known as cytokines in causing Type 2 diabetes, and have identified these molecules as early biological markers that may be used to predict future diabetes in healthy individuals.
Read More